Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium.

Jordan I, Horn D, John K, Sandig V.

Viruses. 2013 Jan 21;5(1):321-39. doi: 10.3390/v5010321.

PMID:
23337383
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.

Meisinger-Henschel C, Späth M, Lukassen S, Wolferstätter M, Kachelriess H, Baur K, Dirmeier U, Wagner M, Chaplin P, Suter M, Hausmann J.

J Virol. 2010 Oct;84(19):9907-19. doi: 10.1128/JVI.00756-10. Epub 2010 Jul 28.

PMID:
20668072
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cell lines from the Egyptian fruit bat are permissive for modified vaccinia Ankara.

Jordan I, Horn D, Oehmke S, Leendertz FH, Sandig V.

Virus Res. 2009 Oct;145(1):54-62. doi: 10.1016/j.virusres.2009.06.007. Epub 2009 Jun 18.

PMID:
19540275
[PubMed - indexed for MEDLINE]
4.

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.

Garber DA, O'Mara LA, Zhao J, Gangadhara S, An I, Feinberg MB.

PLoS One. 2009;4(5):e5445. doi: 10.1371/journal.pone.0005445. Epub 2009 May 6.

PMID:
19421328
[PubMed - indexed for MEDLINE]
Free PMC Article
5.
6.

Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

Hornemann S, Harlin O, Staib C, Kisling S, Erfle V, Kaspers B, Häcker G, Sutter G.

J Virol. 2003 Aug;77(15):8394-407.

PMID:
12857909
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

An avian cell line designed for production of highly attenuated viruses.

Jordan I, Vos A, Beilfuss S, Neubert A, Breul S, Sandig V.

Vaccine. 2009 Jan 29;27(5):748-56. doi: 10.1016/j.vaccine.2008.11.066. Epub 2008 Dec 9.

PMID:
19071186
[PubMed - indexed for MEDLINE]
8.

Modified vaccinia virus Ankara multiplies in rat IEC-6 cells and limited production of mature virions occurs in other mammalian cell lines.

Okeke MI, Nilssen O, Traavik T.

J Gen Virol. 2006 Jan;87(Pt 1):21-7.

PMID:
16361414
[PubMed - indexed for MEDLINE]
Free Article
9.

New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation.

Lohr V, Rath A, Genzel Y, Jordan I, Sandig V, Reichl U.

Vaccine. 2009 Aug 6;27(36):4975-82. doi: 10.1016/j.vaccine.2009.05.083. Epub 2009 Jun 14.

PMID:
19531390
[PubMed - indexed for MEDLINE]
10.
11.

A chemically defined production process for highly attenuated poxviruses.

Jordan I, Northoff S, Thiele M, Hartmann S, Horn D, Höwing K, Bernhardt H, Oehmke S, von Horsten H, Rebeski D, Hinrichsen L, Zelnik V, Mueller W, Sandig V.

Biologicals. 2011 Jan;39(1):50-8. doi: 10.1016/j.biologicals.2010.11.005. Epub 2011 Jan 15.

PMID:
21237672
[PubMed - indexed for MEDLINE]
12.

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine.

Blanchard TJ, Alcami A, Andrea P, Smith GL.

J Gen Virol. 1998 May;79 ( Pt 5):1159-67.

PMID:
9603331
[PubMed - indexed for MEDLINE]
Free Article
13.

Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.

Lohr V, Genzel Y, Jordan I, Katinger D, Mahr S, Sandig V, Reichl U.

BMC Biotechnol. 2012 Oct 30;12:79. doi: 10.1186/1472-6750-12-79.

PMID:
23110398
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Nonreplicating vaccinia vector efficiently expresses recombinant genes.

Sutter G, Moss B.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10847-51.

PMID:
1438287
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Easy and efficient protocols for working with recombinant vaccinia virus MVA.

Kremer M, Volz A, Kreijtz JH, Fux R, Lehmann MH, Sutter G.

Methods Mol Biol. 2012;890:59-92. doi: 10.1007/978-1-61779-876-4_4.

PMID:
22688761
[PubMed - indexed for MEDLINE]
16.

Preparation of cell cultures and vaccinia virus stocks.

Earl PL, Cooper N, Wyatt LS, Moss B, Carroll MW.

Curr Protoc Mol Biol. 2001 May;Chapter 16:Unit16.16. doi: 10.1002/0471142727.mb1616s43.

PMID:
18265123
[PubMed - indexed for MEDLINE]
17.

Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.

Zwilling J, Sliva K, Schwantes A, Schnierle B, Sutter G.

Virology. 2010 Sep 1;404(2):231-9. doi: 10.1016/j.virol.2010.05.008.

PMID:
20627347
[PubMed - indexed for MEDLINE]
Free Article
18.

Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus.

Pollara JJ, Spesock AH, Pickup DJ, Laster SM, Petty IT.

Virology. 2012 Jul 5;428(2):146-55. doi: 10.1016/j.virol.2012.03.019. Epub 2012 Apr 23.

PMID:
22534090
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Vaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice.

Dobson BM, Procter DJ, Hollett NA, Flesch IE, Newsome TP, Tscharke DC.

Virology. 2014 May;456-457:145-56. doi: 10.1016/j.virol.2014.03.020. Epub 2014 Apr 5.

PMID:
24889234
[PubMed - indexed for MEDLINE]
20.

The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

Sperling KM, Schwantes A, Staib C, Schnierle BS, Sutter G.

J Virol. 2009 Jun;83(12):6029-38. doi: 10.1128/JVI.01628-08. Epub 2009 Apr 8.

PMID:
19357172
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk